MetaVia Correlations
| MTVA Stock | 1.73 0.13 6.99% |
The current 90-days correlation between MetaVia and NuCana PLC is 0.02 (i.e., Significant diversification). The correlation of MetaVia is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
MetaVia Correlation With Market
Excellent diversification
The correlation between MetaVia and DJI is -0.53 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding MetaVia and DJI in the same portfolio, assuming nothing else is changed.
Moving together with MetaVia Stock
| 0.7 | DWTX | Dogwood Therapeutics | PairCorr |
| 0.63 | EDIT | Editas Medicine | PairCorr |
| 0.75 | ABP | Abpro Holdings | PairCorr |
| 0.72 | GNLX | Genelux Common | PairCorr |
| 0.71 | KURA | Kura Oncology | PairCorr |
| 0.83 | LYRA | Lyra Therapeutics | PairCorr |
| 0.66 | MBIO | Mustang Bio | PairCorr |
| 0.65 | MREO | Mereo BioPharma Group | PairCorr |
| 0.87 | PRQR | ProQR Therapeutics | PairCorr |
| 0.65 | ACXP | Acurx Pharmaceuticals LLC | PairCorr |
Moving against MetaVia Stock
| 0.69 | ENGN | enGene Holdings Common | PairCorr |
| 0.56 | DSGN | Design Therapeutics | PairCorr |
| 0.49 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.44 | ALT | Altimmune | PairCorr |
| 0.39 | 63E | ONWARD MEDICAL BV | PairCorr |
| 0.37 | KYTX | Kyverna Therapeutics | PairCorr |
| 0.79 | AVCR | Avricore Health | PairCorr |
| 0.73 | ANNX | Annexon | PairCorr |
| 0.61 | MRKR | Marker Therapeutics | PairCorr |
| 0.6 | BOLT | Bolt Biotherapeutics | PairCorr |
| 0.55 | SLDB | Solid Biosciences LLC | PairCorr |
| 0.47 | AVE | Avecho Biotechnology | PairCorr |
| 0.31 | RCKT | Rocket Pharmaceuticals | PairCorr |
| 0.88 | MUFG | Mitsubishi UFJ Financial | PairCorr |
| 0.86 | MBFJF | Mitsubishi UFJ Financial | PairCorr |
| 0.86 | CVX | Chevron Corp | PairCorr |
| 0.84 | KB | KB Financial Group Earnings Call This Week | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between MetaVia Stock performing well and MetaVia Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze MetaVia's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| LSTA | 4.12 | 1.07 | 0.31 | 0.38 | 2.82 | 5.58 | 88.09 | |||
| NCNA | 3.41 | (0.96) | 0.00 | (0.49) | 0.00 | 6.53 | 16.72 | |||
| XCUR | 5.89 | 0.46 | 0.04 | (0.31) | 8.59 | 21.22 | 63.80 | |||
| ENLV | 4.05 | 0.24 | 0.05 | 0.24 | 4.42 | 8.57 | 24.21 | |||
| KLTO | 4.62 | (1.28) | 0.00 | (0.33) | 0.00 | 10.34 | 28.13 | |||
| PASG | 6.03 | 0.40 | 0.08 | 0.11 | 6.70 | 14.59 | 58.13 | |||
| CLSD | 6.75 | (3.00) | 0.00 | (16.39) | 0.00 | 7.96 | 83.67 | |||
| CASI | 3.63 | (0.55) | 0.00 | (0.40) | 0.00 | 5.10 | 32.11 | |||
| SONN | 10.16 | (0.25) | 0.00 | (0.90) | 0.00 | 19.48 | 69.59 | |||
| CLGN | 4.53 | (1.18) | 0.00 | (0.75) | 0.00 | 8.51 | 32.88 |
MetaVia Corporate Management
| Michael Pine | Senior Advisor | Profile | |
| Marshall Woodworth | Chief Officer | Profile | |
| Christopher MD | Consulting Advisor | Profile | |
| Robert Homolka | Senior Operations | Profile | |
| MiKyung Kim | Chief Officer | Profile |